Results 101 to 110 of about 2,864 (172)

Recent advances in tuberculosis treatment: Towards shorter, safer, and more effective therapies. [PDF]

J Clin Tuberc Other Mycobact Dis
Timboe K, Jackson JB, Becker GL.
europepmc   +1 more source

Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients: Study protocol for the PHOENIx phase 3 clinical trial. [PDF]

Contemp Clin Trials
Kendall MA, Hughes MD, Kim S, Aaron LA, Naini L, Suryavanshi N, Shah NS, Rouzier V, Hafkin J, Sise T, Beck J, Heckman BE, Haberer JE, Harrington M, Scarsi KK, Hesseling AC, Swindells S, Churchyard GJ, Gupta A.   +18 more
europepmc   +1 more source

Corrigendum to "Model-Informed Once-Daily Dosing Strategy for Bedaquiline and Delamanid in Children, Adolescents and Adults with Tuberculosis". [PDF]

Clin Pharmacol Ther
europepmc   +1 more source

The pharmacokinetics (PK) / pharmacodynamics (PD) of pretomanid, delamanid and bedaquiline in the BALB/c mouse model of central nervous system tuberculosis. [PDF]

BMC Infect Dis
Zhu H, Ye Y, Fu L, Zhang W, Wang B, Chen X, Lu Y.   +6 more
europepmc   +1 more source

A New Era in Tuberculosis Prevention and Treatment: Breakthroughs in Drug Development and Future Prospects. [PDF]

Infect Dis Ther
Zhao CY, Song C, Lu YB, Huang AC, Zeng CM, Liu RH, Li WW, Xie ZH, Zhu QD.   +8 more
europepmc   +1 more source

New drugs for the management of tuberculosis. [PDF]

Curr Opin Infect Dis
Cross GB.
europepmc   +1 more source

QT interval prolongation in patients receiving bedaquiline-based regimens for drug-resistant tuberculosis in Sub-Saharan Africa: A systematic review and meta-analysis. [PDF]

J Clin Tuberc Other Mycobact Dis
Okello MO, Pitua I, Okema JN, Ekwem D, Bongomin F, Olum R.   +5 more
europepmc   +1 more source

Effectiveness and safety of a shortened oral regimen for rifampicin- or multidrug-resistant TB. [PDF]

IJTLD Open
Herrera-Flores E, Shen E, Vargas-Vasquez D, Llanos-Tejada F, Ruiz-Vargas Z, Cornejo-García J, Vela-Trejo D, Puyen-Guerra ZM, Rojas MC, Guerra DM, Romo ML, Jimenez J, Osso E, Trevisi L, LaHood A, Rich ML, Seung KJ, Mitnick CD, Franke MF, Lecca L, Alarcon-Guizado V.   +20 more
europepmc   +1 more source

An assay toolkit for anti-tuberculosis drugs in the hollow fiber system. [PDF]

iScience
Sanz-García F, Ndjogou D, Aguilar-Ayala DA, Eveque-Mourroux MR, Benítez A, Aznar S, Isach-Traver N, Mendoza-Losana A, Willand N, Lucía A, Ramón-García S, ERA4TB consortium.   +11 more
europepmc   +1 more source

Multidrug-Resistant Tuberculosis in Central and Eastern Europe: Implementation and Maturity of Whole-Genome Sequencing for Surveillance. [PDF]

Diseases
Baiceanu D, Chivu LI, Coriu RM, Stoichita A, Panciu TC, Zaharia DC, Mahler B, Matei A, Ibraim E, Manolescu LSC.   +9 more
europepmc   +1 more source